Nutrition
Volume 26, Issue 9 , Pages 910-914 , September 2010

Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis

  • Sylvie Dusilová Sulková, M.D.

      Affiliations

    • Division of Nephrology, Department of Gerontology and Metabolism, Medical Faculty of Charles University and Faculty Hospital, Hradec Králové, Czech Republic
    • ,
  • Martin Válek, M.D.

      Affiliations

    • 2nd Internal Department—Department of Cardiology and Angiology, First Medical Faculty of Charles University and General University Hospital, Prague, Czech Republic
    • Department of Internal Medicine Strahov, General University Hospital, Prague, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +420 602940008; fax: +420 257214793.

Received 13 October 2009 ,Accepted 23 January 2010.

References 

  1. Kuypers DR. Skin problems in chronic kidney disease. Nat Clin Pract Nephrol. 2009;5:157–170
  2. Rogers NM, Coates PTH. Calcific uraemic arteriolopathy: an update. Curr Opinion Nephrol Hypertens. 2008;17:629–634
  3. Rogers NM, Teubner DJO, Coates PTH. Calcific uremic arteriolopathy: advances in pathogenesis and treatment. Semin Dial. 2007;20:150–157
  4. Burke SK. Phosphate is a uremic toxin. J Ren Nutr. 2008;18:27–32
  5. Cozzolino M, Gallieni M, Brancaccio D. The mechanisms of hyperphosphatemia-induced vascular calcification. Int J Artif Organs. 2008;31:1002–1003
  6. Nikolov IG, Mozar A, Drüeke TB, Massy ZA. Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease. Blood Purif. 2009;27:350–359
  7. Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. Am J Acad Dermatol. 2007;56:569–579
  8. Mazhar AR, Johnson RJ, Fillem D, Stivelman JC, Ryan MJ, Davis CL, et al. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kid Int. 2001;60:324–332
  9. Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008;3:1139–1143
  10. Arseculeratne G, Evans AT, Morley SM. Calciphylaxis–-a topical overview. J Eur Acad Der Venerol. 2006;20:493–502
  11. Hayden MR, Goldsmith D, Sowers JR, Khanna R. Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate. Int Urol Nephrol. 2008;40:443–451
  12. Raymond CB, Wazny LD. Sodium thiosulfate, bisfospfonates, and cinacalcet for treatment of calciphylaxis. Am J Health Syst Pharm. 2008;65:1419–1429
  13. Monney P, Nguzen QV, Perroud H, Descobes E. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19:2130–2132
  14. Arenales MD, Gil MT, Gutierrez MD, Malek T, Moledous A, Salinas A, et al. Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy. Clin Nephrol. 2008;70:261–264
  15. Basile C, Montanaro A, Masi M, Pati G, De Maio P, Gismondi A. Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. J Nephrol. 2002;15:676–680
  16. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003;42(suppl 3):S1–S202
  17. Hafner J, Keusch G, Wahl C, Sauter B, Hürlimann A, von Weizsäcker F, et al. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyreoidectomy. J Am Acad Dermatol. 1995;33:954–962
  18. Girotto JA, Harmon JW, Retner LE, Nicol TL, Wong L, Chen H. Parathyreoidectomy promotes wound healing and prolongs survival in patiens with calciphylaxis from secondary hyperparathyroidism. Surgery. 2001;130:645–651

 Sylvie Dusilová Sulková was responsible for conception and design of article, drafting and revision of manuscript, and approval of the final version of manuscript. Martin Válek was responsible for the collection and assembly of data, drafting and revision of manuscript, and approval of the final version of manuscript.

PII: S0899-9007(10)00056-0

doi: 10.1016/j.nut.2010.01.018

Nutrition
Volume 26, Issue 9 , Pages 910-914 , September 2010

Article Tools

* Image Usage & Resolution